NCAM1 and breast carcinoma: In this study, NK-92 cells labeled with Fe3O4-PEG-CD56/Avastin@Ce6 were used for in vitro and in vivo breast cancer adoptive cellular immunotherapy and PDT as well as MR/optical dual-modal imaging (Fig. 1).